Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A university research team is exploring a new way to treat liver disease. Researchers at the University of Sunderland, led by ...

Liver fibrosis often develops without symptoms and has no approved cure. But researchers at the University of Sunderland have ...

Methods involving the use of photo-, enzyme-, and transition metal-catalyzed modification ... Simple incorporation of residue-reactive warheads can convert reversible inhibitors into irreversible ones ...

Asandeutertinib is a derivative of Tagrisso designed to avoid certain toxic side effects in patients with EGFR-mutated NSCLC.

Bayer’s Vividion Therapeutics has secured the global rights from its partner Roche to the only Werner helicase (WRN) ...

When given as an intravenous bolus, immediate and full platelet inhibition of ADP-induced platelet aggregation was observed. The clinical efficacy and safety of elinogrel will be further evaluated ...

The angiotensin‐receptor neprilysin inhibitor (ARNI) sacubitril/valsartan was shown to be superior to the angiotensin‐converting enzyme inhibitor enalapril in terms of reducing cardiovascular ...

Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui 230031, P. R. China Hefei Cancer Hospital, Chinese Academy of Sciences, ...